Bone marrow NK cell subsets in patients with NDMM and control subjects. (A) Bone marrow CD3^–CD56⁺CD16⁺ NK cells in patients with NDMM and in control subjects. (B) Proportions of NK56^bright and NK56^dim subsets in bone marrow of patients with NDMM and control subjects.